These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17961036)

  • 1. Targeted drug therapy for meningiomas.
    Norden AD; Drappatz J; Wen PY
    Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapies for meningiomas.
    Wen PY; Drappatz J
    Expert Rev Neurother; 2006 Oct; 6(10):1447-64. PubMed ID: 17078786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of recurrent meningiomas.
    Chamberlain MC; Barnholtz-Sloan JS
    Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy: What is its role in meningioma?
    Sherman WJ; Raizer JJ
    Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Medical Therapies in Meningiomas.
    Danish H; Brastianos P
    Adv Exp Med Biol; 2023; 1416():213-223. PubMed ID: 37432630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea chemotherapy in the treatment of meningiomas.
    Newton HB
    Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade meningiomas: new avenues for drug treatment?
    Preusser M; Berghoff AS; Hottinger AF
    Curr Opin Neurol; 2013 Dec; 26(6):708-15. PubMed ID: 24184974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.
    Karsy M; Guan J; Cohen A; Colman H; Jensen RL
    Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of meningiomas.
    Chukwueke UN; Wen PY
    Handb Clin Neurol; 2020; 170():291-302. PubMed ID: 32586501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in chemotherapy for meningiomas: a review.
    Moazzam AA; Wagle N; Zada G
    Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in meningioma genetics: novel therapeutic opportunities.
    Preusser M; Brastianos PK; Mawrin C
    Nat Rev Neurol; 2018 Feb; 14(2):106-115. PubMed ID: 29302064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of meningiomas.
    Alexiou GA; Gogou P; Markoula S; Kyritsis AP
    Clin Neurol Neurosurg; 2010 Apr; 112(3):177-82. PubMed ID: 20056312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
    Chamberlain MC
    Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of high risk or recurrent meningiomas with hydroxyurea.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea for treatment of unresectable meningiomas.
    Schrell UM; Rittig MG; Koch U; Marschalek R; Anders M
    Lancet; 1996 Sep; 348(9031):888-9. PubMed ID: 8826822
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy and targeted therapies for meningiomas: what is the evidence?
    Graillon T; Tabouret E; Chinot O
    Curr Opin Neurol; 2021 Dec; 34(6):857-867. PubMed ID: 34629433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma.
    Kato Y; Nishihara H; Mohri H; Kanno H; Kobayashi H; Kimura T; Tanino M; Terasaka S; Tanaka S
    Brain Tumor Pathol; 2014 Jan; 31(1):23-30. PubMed ID: 23250387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update Knowledge for Brain Tumors(7)Meningioma].
    Kawahara N
    No Shinkei Geka; 2016 May; 44(5):415-30. PubMed ID: 27166847
    [No Abstract]   [Full Text] [Related]  

  • 20. Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs.
    Dasanu CA; Alvarez-Argote J; Limonadi FM; Codreanu I
    Expert Opin Biol Ther; 2019 Feb; 19(2):99-104. PubMed ID: 30556741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.